Clinical trial
Trial of Amlodipine Combined With Botulinum Toxin Injections for Focal Dystonia
NCT00015457 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Trial of Amlodipine Combined With Botulinum Toxin Injections for Focal Dystonia
- Lead sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2001
- Completion date
- Not reported
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
focal dystonia